What Thyrocare Technologies does

Thyrocare Technologies Limited, founded in 1995 by Dr. Arokiaswamy Velumani in Mumbai, operates India's first fully automated diagnostic laboratory network and is listed on the NSE under ticker THYROCARE. The company's core offering is a 1,200+ test menu delivered through a hub-and-spoke architecture comprising 1 central processing lab in Navi Mumbai, 3 zonal labs, and 35+ regional processing labs, processing 75,000+ samples daily and reaching 4,500+ serviceable pincodes via 900+ phlebotomists and an Aarogyam franchise network. Its product portfolio centers on the Aarogyam full-body checkup series (59–146+ tests, ₹549–₹6,499), gender- and age-segmented packages, and specialty Jaanch panels, supplemented by radiology, home ECG (via Think Health), food diagnostics (via Vimta Labs), and newly launched genomics and NIPT services.

Revenue is generated primarily through per-test transaction fees on B2C volume booked via the Thyrocare website and mobile app, recurring franchise and channel partner fees from 900+ Aarogyam Centers, and B2B corporate wellness contracts. The company serves individual consumers seeking affordable preventive screening, corporates running employee health programs, and franchise partners operating under the Thyrocare brand. Since 2021, Thyrocare has operated as a majority-owned subsidiary of API Holdings (PharmEasy); it holds 100% NABL and CAP accreditation, was recognized as Best Diagnostic Lab Chain of the Year in 2026, and reported FY26 revenue of Rs 829.04 crore (+21% YoY), Rs 162.85 crore net profit (+81% YoY), and 209.6 million tests processed (+23% YoY). Expansion has accelerated through three acquisitions in 2024 (Think Health, Polo Labs' 14 northern India labs, Vimta Labs) and a 2026 entry into genomics and advanced allergy testing.

Name

Thyrocare Technologies

Legal name

Thyrocare Technologies Limited

Website

https://thyrocare.com

Company type

Public

Founded year

1995

Operating status

Operating

Headcount range

501–1,000 employees

Ownership category

akta.pro rank

Product category

Diagnostic Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Diagnostic Imaging Centers (621512)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

At-Home Lab Testing & Diagnostics-Integrated Virtual Care (HLALAAAE)

akta.pro secondary industry

Quality, Peer Review & Compliance Tools (MQSA/ACR/QA) (HLACALAL)

Keywords

• Diagnostic laboratory services
• Preventive health checkups
• Pathology testing services
• Medical diagnostics
• Lab franchise operations

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Operations, Personnel, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Diagnostic Testing Services: Core revenue from processing and reporting diagnostic tests for patients, hospitals, and clinics. Revenue from operations grew 19.30% to Rs 182 Crore in Q3 FY26, with segment profit before tax of Rs 36.8 Crore.
2. Franchise Partnerships: Revenue from franchisee partners who operate Aarogyam Centers under the Thyrocare brand. Franchisees pay for sample collection services and use Thyrocare's lab infrastructure.
3. B2B Corporate Partnerships: Corporate partnerships and channel partnerships for employee health checkups and diagnostic services

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Core offering

Thyrocare Technologies operates one of India's first fully automated diagnostic laboratories, offering 1,200+ pathology and radiology tests through home sample collection and direct online booking. The company sells preventive health packages (Aarogyam, HerCheck, Jaanch), specialized tests (allergy, NIPT, food-handler), and runs an Aarogyam Centre franchise network across India.

Product overview

Thyrocare Technologies operates as a diagnostic and preventive healthcare services company offering a comprehensive portfolio organized around a core platform of pathology testing with multiple product lines. The main offering consists of the Aarogyam Series of full body checkup packages (ranging from basic 59-test packages to premium 146+ test packages), complemented by gender-specific packages (Men's Health and Women's Health/HerCheck), health concern-based screenings (Heart, Diabetes, Thyroid, Cancer, etc.), and specialty Jaanch packages. The company provides radiology services through a separate platform, home ECG services via the acquired Think Health Diagnostics, and food handler testing under FSSAI compliance. Services are delivered through a franchise model with PAN-India reach, supported by 35+ Regional Processing Labs, 3 Zonal labs, and 1 Central Processing Lab, processing 75,000+ samples daily across 4,500+ serviceable pincodes.

Differentiator

Problem solved

Functional benefit

Products and services

• Aarogyam Series Packages
• HerCheck Packages
• Jaanch Packages
• Radiology Services
• Home ECG Services (Think Health)
• Food Handler Testing
• Lab Franchise Program (Aarogyam Centres)
• Genomics Laboratory
• Advanced Allergy Testing
• Non-invasive Prenatal Testing (NIPT)

Quantifiable outcome

• 98% reports delivered within 6 hours of sample reaching lab
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered regional and core.

• Vimta Labs LimitedregionalStrategic or Co-development Partner · 1 September 2024Thyrocare acquired Vimta Labs Limited in September 2024 to expand its food diagnostics capabilities and diversify its healthcare portfolio.
• Polo LabsregionalStrategic or Co-development Partner · 25 July 2024Thyrocare acquired Polo Labs' pathology diagnostics business including 14 laboratories in Punjab, Haryana, and Himachal Pradesh to expand presence in northern India. This acquisition strengthened Thyrocare's diagnostic capabilities and regional footprint.
• Think Health DiagnosticcoreStrategic or Co-development Partner · 27 February 2024Thyrocare completed acquisition of 100% equity shares in Think Health Diagnostic Private Limited on February 27, 2024, making it a wholly-owned subsidiary. Think Health provides home ECG services, expanding Thyrocare's presence in the pre-policy medical check-up market.

Scale indicators9 records

Recent moves6 records

Expansion highlights7 records

Direct peers

• Dr. Lal PathLabs: Dr. Lal PathLabs is India's largest diagnostic chain by revenue and the most direct competitor to Thyrocare, offering a similar pan-India network of pathology labs, home sample collection, preventive health packages, and a comparable test menu. Both compete for B2C patients and B2B franchise/partner relationships.
• Agilus Diagnostics (formerly SRL Diagnostics): Agilus Diagnostics operates one of India's largest diagnostic networks with hundreds of collection centers and reference labs, directly competing with Thyrocare across routine pathology, preventive health packages, and B2B hospital lab management services.
• Metropolis Healthcare: Metropolis Healthcare is a major pan-India diagnostic chain with a comparable focus on pathology testing, preventive health checkups, and home collection services. It competes directly with Thyrocare in metro and tier-1 markets and pursues similar specialty testing expansion strategies.
• Apollo Diagnostics: Apollo Diagnostics is the diagnostics arm of Apollo Hospitals, offering pathology, radiology, and home sample collection services across India. It competes with Thyrocare through hospital network advantages and an integrated care offering for both walk-in and online customers.
• Suburban Diagnostics: Suburban Diagnostics is a major Western India-based diagnostic chain (headquartered in Mumbai like Thyrocare) offering pathology, preventive health packages, and home collection services. It competes directly for customers and franchise partners in Maharashtra and surrounding states.

Emerging players

• Max Lab (Max Healthcare): Max Lab is the diagnostics arm of Max Healthcare, offering pathology and radiology services through hospital labs and home collection. It is an emerging peer that leverages hospital trust to compete with Thyrocare for premium preventive health customers in North India.
• Neuberg Diagnostics: Neuberg Diagnostics is a pan-India and international diagnostic chain that has grown rapidly through an aggregator model of regional labs. It competes with Thyrocare on routine pathology while emphasizing specialty and super-specialty testing in markets including India, UAE, and South Africa.
• Tata 1mg: Tata 1mg is a digital health platform offering e-pharmacy, online doctor consultations, and diagnostic test booking with home sample collection. It competes with Thyrocare for digital-first B2C diagnostic customers and represents the digital-native channel that is reshaping Indian preventive healthcare.

Broad incumbents

• PharmEasy (API Holdings): PharmEasy is Thyrocare's parent company and India's largest e-pharmacy platform (~35% market share). It is a peer in the broader digital healthcare ecosystem, competing with standalone diagnostic platforms and integrating Thyrocare's lab services into its online consumer offering.

Regional players

• Vijaya Diagnostic Centre: Vijaya Diagnostic Centre is a leading South India diagnostic chain with strong presence in Telangana and Andhra Pradesh. It offers comparable pathology and preventive health services but is regionally concentrated, making it a relevant peer for market share dynamics in southern India where Thyrocare also competes.

Market position

Strengths5 records

Weaknesses1 record

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/thyrocare
• Facebookfacebook.com/thyrocare
• LinkedInlinkedin.com/company/thyrocare-technologies-ltd

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries2 records

Funding overview

Funding rounds5 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Thyrocare Technologies